{
  "url": "https://seekingalpha.com/article/4813901-talphera-inc-tlph-q2-2025-earnings-call-transcript",
  "authorsByline": "SA Transcripts",
  "articleId": "933d659840474b9eaa81bc8070d51fae",
  "source": {
    "domain": "seekingalpha.com",
    "location": {
      "country": "us",
      "state": "NY",
      "city": "New York",
      "coordinates": {
        "lat": 40.7127281,
        "lon": -74.0060152
      }
    }
  },
  "imageUrl": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-15T01:10:33+00:00",
  "addDate": "2025-08-15T01:13:30.109574+00:00",
  "refreshDate": "2025-08-15T01:13:30.109575+00:00",
  "score": 1.0,
  "title": "Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript",
  "description": "Talphera, Inc. (NASDAQ:TLPH) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ETCompany ParticipantsRaffi Mark Asadorian - Chief Financial...",
  "content": "Welcome to the Talphera Second Quarter 2025 Financial Results Conference Call. This call is being webcast live via the Events page of the Investors section of Talphera's website at www.talphera.com. You may listen to a replay of this webcast by going to the Investors section of Talphera's website.\n\nI would now like to turn the call over to Raffi Asadorian, Talphera's Chief Financial Officer.\n\nThanks, Andrew, and thank you for joining us on the call today. Today, we announced our second quarter 2025 financial results and associated business updates in a press release. With me today are Vincent Angotti, our Chief Executive Officer; and Dr. Shakil Aslam, Talphera's Chief Medical Officer.\n\nBefore we begin, I want to remind listeners that during this call, we will likely make forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks and uncertainties regarding the operations and future results of Talphera. Please refer to our press release in addition to the company's periodic current and annual reports filed with the Securities and Exchange Commission for a discussion of the risks associated with such forward-looking statements. These documents can be found on our website within the Investors section.\n\nI'll now hand the call to Vince.\n\nThanks, Raffi. Good afternoon, and thank you to everyone joining our call today. We're excited about the progress made this past quarter, specifically in the acceleration of the NEPHRO study",
  "medium": "Article",
  "links": [
    "https://seekingalpha.com/symbol/TLPH"
  ],
  "labels": [
    {
      "name": "Opinion"
    },
    {
      "name": "Roundup"
    },
    {
      "name": "Non-news"
    }
  ],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "Talphera",
      "weight": 0.10251384
    },
    {
      "name": "the Talphera Second Quarter 2025 Financial Results Conference Call",
      "weight": 0.080993526
    },
    {
      "name": "future results",
      "weight": 0.08072979
    },
    {
      "name": "Talpheras Chief Financial Officer",
      "weight": 0.07596166
    },
    {
      "name": "Talpheras Chief Medical Officer",
      "weight": 0.07593132
    },
    {
      "name": "Dr. Shakil Aslam",
      "weight": 0.072251715
    },
    {
      "name": "associated business updates",
      "weight": 0.071821086
    },
    {
      "name": "Raffi Asadorian",
      "weight": 0.068982765
    },
    {
      "name": "Q2 2025 Earnings Call Transcript",
      "weight": 0.06633064
    },
    {
      "name": "Today",
      "weight": 0.06618226
    }
  ],
  "topics": [
    {
      "name": "Markets"
    },
    {
      "name": "Earnings Calls"
    }
  ],
  "categories": [
    {
      "name": "Finance"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Company News",
      "score": 0.9921875
    },
    {
      "name": "/News/Business News/Financial Markets News",
      "score": 0.97412109375
    },
    {
      "name": "/Finance/Investing/Stocks & Bonds",
      "score": 0.9677734375
    },
    {
      "name": "/Business & Industrial/Pharmaceuticals & Biotech",
      "score": 0.5126953125
    }
  ],
  "sentiment": {
    "positive": 0.40599936,
    "negative": 0.051920358,
    "neutral": 0.5420803
  },
  "summary": "The Talphera Second Quarter 2025 Financial Results Conference Call is being webcast live via the Events page of the Investors section of the company's website. With representatives from the company, Vincent Angott, and Dr. Shakil Aslam, are discussing the company\u2019s financial results and business updates. The company's forward-thinking statements are likely to be made in accordance with current laws and are subject to numerous risks and uncertainties.",
  "shortSummary": "The Talphera Q2 2025 earnings call will be broadcast live via YouTube, with keynotes from CEO Vincent Angorn and CFO Raffi Asadorian highlighting their progress.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": true,
  "reprintGroupId": "4b4c1971d06d40b69e160b8d6f1f4792",
  "places": [],
  "scraped_sources": [],
  "argos_summary": "Talphera held a conference call to discuss its second quarter 2025 financial results, featuring key executives including CFO Raffi Asadorian, CEO Vincent Angotti, and CMO Dr. Shakil Aslam. The call highlighted the company's progress, particularly in the NEPHRO study, and included forward-looking statements that carry associated risks. Listeners were reminded to refer to the company's press release and SEC filings for more information.",
  "argos_id": "AVUDNYN9M"
}